U.S. Insurance Stock News

Figma stock snapshot after recent trading moves Figma (FIG) has drawn fresh attention after a recent pullback, with the share price closing at US$28.35 and short term returns mixed across the past week, month, and past 3 months. See our latest analysis for Figma. The recent 7 day share price return of 7.77% and 1 day decline of 6.99% come after a strong 30 day share price return of 28.92%. However, the year to date share price return of 24.62% and 90 day share price return of 27.79% indicate...

If you are wondering whether FactSet Research Systems is attractively priced or still looks expensive, this article will walk through what the numbers are really saying about its current valuation. The share price closed at US$212.01, with returns of a 4.9% decline over 7 days, 2.3% over 30 days, a 25.6% decline year to date, a 50.1% decline over 1 year, a 46.5% decline over 3 years, and a 29.9% decline over 5 years, which may have changed how investors view its risk and return...

In recent quarters, Analog Devices reported quarterly revenue growth of 30% and guided for record Q2 revenue of about US$3.50 billion, driven by broad industrial strength and surging AI data center demand. An interesting element of this update is management’s view that the upswing reflects genuine end-market demand rather than temporary channel restocking, underscoring the depth of industrial and AI-related orders. Next, we’ll examine how this surge in genuine AI data center demand may...

If you are wondering whether Sysco is priced fairly today or if there is still value left on the table, this article walks you through what the numbers are really saying about the stock. Sysco shares last closed at US$84.29, with returns of 16.1% year to date and 16.3% over the past year, despite a 4.2% decline over 7 days and a 2.6% decline over 30 days that may be shifting how some investors see the risk and reward balance. Recent coverage has focused on Sysco's position as a major...

Four Corners Property Trust (NYSE:FCPT) has acquired automotive service properties in Texas and Indiana. Each property is operated under a long term triple net lease with a national automotive service tenant. The transactions extend FCPT’s reach beyond casual dining into essential, car focused retail locations. For you as an investor, these new deals highlight how Four Corners Property Trust, known for its net lease portfolio centered on restaurants, is adding more automotive service assets...

Coherus Oncology (CHRS) just posted its FY 2025 numbers with Q4 revenue of US$12.7 million and a basic EPS loss of US$0.39, while trailing 12 month figures show revenue of US$42.2 million and a basic EPS loss of US$1.56. Over recent quarters, the company has seen revenue move from US$7.6 million in Q1 2025 to US$12.7 million in Q4 2025, with quarterly basic EPS losses in a tight band around US$0.38 to US$0.41. This keeps the focus squarely on how efficiently each extra dollar of sales is...

In February 2026, Innoviva, Inc. reported fourth-quarter 2025 revenue of US$114.61 million and net income of US$164.15 million, alongside full-year revenue of US$411.33 million and net income of US$271.17 million, all higher than the prior year. An interesting feature of this release is the sharp increase in basic earnings per share from continuing operations, with quarterly EPS rising to US$2.19 and full-year EPS reaching US$4.02 compared with the previous year. We’ll now explore how...

If you are wondering whether Expand Energy at US$104.67 is still worth your attention or if most of the upside has already been priced in, this article breaks down what the current share price might be implying about value. The stock has recently seen a 3.1% decline over 7 days and is down 5.2% over 30 days, even though the 1-year return sits at 7.6% and the 5-year return is a very large gain of around 2x. Recent coverage around Expand Energy has focused on its position within the energy...

BioMarin Pharmaceutical Inc. recently received FDA approval for a supplemental Biologics License Application expanding PALYNZIQ (pegvaliase-pqpz) use to pediatric phenylketonuria patients aged 12 and older, based on PEGASUS Phase 3 safety and efficacy data. This approval broadens PALYNZIQ’s eligible patient population but comes with a REMS restriction due to immune-mediated risks including anaphylaxis, highlighting both opportunity and safety management demands for BioMarin. We’ll now...

In early March 2026, Eaton announced a partnership with SPAN, investing US$75,000,000 to co-develop smart electrical panels that support affordable home electrification and reduce grid infrastructure needs, with joint solutions targeted for release in the second quarter of 2026. This move extends Eaton’s “Home as a Grid” approach by pairing its distribution and protection hardware with SPAN’s energy intelligence software, potentially deepening Eaton’s role in managing household energy use...

Burford Capital (NYSE:BUR) has been in focus after its Q4 2025 earnings showed lower revenue, a quarterly net loss, and reduced earnings per share, alongside insider share purchases and a new repurchase program. See our latest analysis for Burford Capital. At a share price of US$8.28, Burford Capital has had a softer run recently, with a 30 day share price return of 7.17% and a year to date share price return of 5.37%. The 1 year total shareholder return of a 36.94% decline contrasts with...

What the recent aerospace deals tell you about Curtiss-Wright Curtiss-Wright (CW) has been in focus after two recent aerospace and defense wins: a new partnership with Averna to build custom aerospace test systems and a four year U.S. Department of Defense contract for helicopter support equipment. See our latest analysis for Curtiss-Wright. The recent Averna partnership and U.S. Department of Defense contract arrive as Curtiss-Wright’s share price trades at US$703.61, with a 30-day share...

Arcus Biosciences recently reported full-year 2025 results, with revenue of US$247 million versus US$258 million in 2024 and a net loss of US$353 million, while also granting new employee equity awards under its 2020 Inducement Plan. More importantly for the story, Arcus outlined encouraging new clinical data and expansion plans for its HIF-2α inhibitor casdatifan in kidney cancer, alongside moves into inflammatory and autoimmune diseases that could reshape how investors view its pipeline...

In early March 2026, Western Alliance Bancorporation sued Jefferies Financial Group over a US$126.4 million commercial loan tied to allegedly fraudulent First Brands Group receivables, while Jefferies simultaneously continued issuing long-dated senior unsecured notes across multiple fixed-income offerings. Jefferies has firmly rejected Western Alliance’s claims, highlighting the non-recourse structure of the disputed loans and disclosing related regulatory and legal scrutiny, including an...

Compañía de Minas BuenaventuraA (BVN) has put income and earnings in focus after its board proposed a US$0.9904 per share dividend, alongside detailed fourth quarter and full year 2025 results. See our latest analysis for Compañía de Minas BuenaventuraA. Those earnings and dividend headlines come after a very strong run in the stock, with a 44.99% 90 day share price return, a 36.06% year to date share price return and a 1 year total shareholder return of 192.62%. This suggests momentum has...

Context for Fortinet after recent performance Fortinet (FTNT) continues to draw attention after recent share price moves, with a 1 day return of 0.5%, about 3.8% over the past week and a modest gain over the past month. Investors are also weighing its roughly 3.2% return over the past 3 months and 8.1% year to date, against a 14.3% negative 1 year total return and longer term gains over 3 and 5 years. See our latest analysis for Fortinet. At a share price of $84.20, Fortinet’s recent positive...

If you are wondering whether Thermo Fisher Scientific at around US$500 per share still offers solid value, this article will walk through what the current price really implies. The stock is currently around US$500.08, with returns of a 1.6% decline over 7 days, 7.9% decline over 30 days, 15.6% decline year to date, 2.4% decline over 1 year and 9.3% decline over 3 years, while the 5 year return sits at 13.4%. Recent news coverage has focused on Thermo Fisher Scientific's role as a key...

NextEra Energy (NEE) is back in focus after chief risk officer Terrell Kirk Crews II announced his resignation, effective March 20, 2026, leaving investors weighing what this means for risk oversight. See our latest analysis for NextEra Energy. Recent events, including the chief risk officer’s planned exit and a US$2b composite units offering, have come against a backdrop of building momentum. The 30 day share price return of 2.31% and the 90 day share price return of 12.64%, alongside the 1...

Tilray Brands has completed its acquisition of BrewDog Brewing Australia, expanding its beverage platform into the Asia Pacific region. The deal adds an Australian production facility, bar network, and new distribution channels to Tilray’s existing BrewDog UK relationship. This move is described by the company as its most significant international step in beverages so far. Tilray Brands, traded as NasdaqGS:TLRY, now pairs its existing BrewDog UK exposure with a direct operating footprint in...

OPENLANE (OPLN) has drawn investor attention after recently trading around US$28.34. Its mixed share performance over the past month and past 3 months has prompted closer scrutiny of its wholesale used vehicle marketplace business. See our latest analysis for OPENLANE. Looking beyond the recent pullback, OPENLANE’s 1 day share price return of 1.73% and 30 day share price return of a 3.70% decline contrast with a 1 year total shareholder return of 36.58% and 3 year total shareholder return of...

Kohl's (KSS) has wrapped up FY 2026 with fourth quarter revenue of US$5,173 million and basic EPS of US$1.12, anchored by net income of US$125 million. Trailing 12 month basic EPS sits at US$2.43 on revenue of US$15,527 million. Over the past few quarters, the company has seen quarterly revenue move from US$3,233 million in Q1 2026 to US$5,173 million in Q4 2026, with basic EPS ranging from a loss of US$0.14 in Q1 2026 to US$1.12 in Q4 2026. Trailing 12 month EPS has risen from US$1.09 at Q1...

Firefly Aerospace recently conducted its Alpha Flight 7 mission from Vandenberg Space Force Base, serving as the final test flight of the rocket’s Block I configuration while also evaluating several Block II systems in a live launch environment. This combined Block I close‑out and Block II validation flight is important because it aims to accelerate upgrades that are intended to improve Alpha’s reliability, production efficiency and mission versatility across national security, hypersonic...

Repay Holdings FY 2025 results: revenue steady, losses weigh on margins Repay Holdings (RPAY) has wrapped up FY 2025 with Q4 revenue of US$78.6 million and a basic EPS loss of US$1.71, capping a year in which trailing 12 month revenue came in at US$309.3 million alongside a net loss of US$256.7 million. Over recent quarters the company has seen quarterly revenue move in a tight band between US$75.6 million and US$79.1 million, while quarterly basic EPS has ranged from a loss of US$1.71 to a...

Futu Holdings (FUTU) is back in focus as traders position ahead of its imminent fourth quarter and full year 2025 earnings release, with optimism tied to options activity and upbeat analyst commentary. See our latest analysis for Futu Holdings. The recent 7.2% one day share price return to US$153.58 builds on a 6.1% seven day share price gain, yet follows a 90 day share price decline of 11.4%. This leaves the year to date share price return at 13.9% lower, while the one year total shareholder...